Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma

被引：0
|
作者：
J. Cho
S. Y. Kim
Y. J. Kim
M. H. Sim
S. T. Kim
N. K. D. Kim
K. Kim
W. Park
J. H. Kim
K.-T. Jang
J. Lee
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology
[2] Samsung Medical Center,Oncology, Department of Medicine, Samsung Medical Center
[3] Samsung Medical Center,Samsung Biomedical Research Institute
[4] Sungkyunkwan University School of Medicine,Samsung Genome Institute
[5] Sungkyunkwan University School of Medicine,Department of Surgery, Samsung Medical Center
来源：
Clinical and Translational Oncology | 2017年 / 19卷
关键词：
KIT; Melanoma; Imatinib; Acquired resistance; CTNNB1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1247 / 1252
页数：5
相关论文
共 50 条
  • [1] Emergence of CTNNB1 mutation at acquired resistance to KIT inhibitor in metastatic melanoma
    Cho, J.
    Kim, S. Y.
    Kim, Y. J.
    Sim, M. H.
    Kim, S. T.
    Kim, N. K. D.
    Kim, K.
    Park, W.
    Kim, J. H.
    Jang, K. -T.
    Lee, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1247 - 1252
  • [2] Glomangiopericytoma with CTNNB1 mutation
    Iwata, Shinji
    Kitazawa, Riko
    Kitazawa, Sohei
    Hato, Naohito
    BMJ CASE REPORTS, 2023, 16 (09)
  • [3] Acquired CTNNB1 Mutation Drives Immune Checkpoint Inhibitor-Acquired Resistance in a Microsatellite Instability-High Gastroesophageal Adenocarcinoma With Brain Metastases
    Klempner, Samuel J.
    Schrock, Alexa B.
    Ali, Siraj M.
    Kubicky, Charlotte D.
    Taylor, Matthew H.
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 6
  • [4] Superficial fibromas with CTNNB1 mutation
    Kuntze, Anna
    Meliss, R. R.
    Ermert, L.
    Falkenberg, K. D.
    Puller, A. C.
    Trautmann, M.
    Hartmann, W.
    Wardelmann, E.
    GENES CHROMOSOMES & CANCER, 2024, 63 (05):
  • [5] The significance of CTNNB1 mutation in endometrial cancer
    Tuerlinckx, Charlotte
    Vanden Bempt, Isabelle
    Van Rompuy, Anne-Sophie
    Baert, Thais
    Amant, Frederic
    Olbrecht, Siel
    Van De Putte, Toon
    Van Nieuwenhuysen, Els
    Van Gorp, Toon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A48 - A49
  • [6] CTNNB1 Mutation in Aldosterone Producing Adenoma
    Wang, Jian-Jhong
    Peng, Kang-Yung
    Wu, Vin-Cent
    Tseng, Fen-Yu
    Wu, Kwan-Dun
    ENDOCRINOLOGY AND METABOLISM, 2017, 32 (03) : 332 - 338
  • [7] CTNNB1 mutation can mediate resistance to EGFR, ALK and KRAS targeted therapies
    Majumder, Anurima
    Meyer, Benjamin S.
    Hicks, J. Kevin
    Boyle, Theresa A.
    Haura, Eric B.
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Transcriptomic Characterization of Hepatocellular Carcinoma with CTNNB1 Mutation
    Ding, Xiao
    Yang, Yuan
    Han, Baoda
    Du, Chengzhi
    Xu, Naiqing
    Huang, Huanwei
    Cai, Tao
    Zhang, Aiqun
    Han, Ze-Guang
    Zhou, Weiping
    Chen, Liang
    PLOS ONE, 2014, 9 (05):
  • [9] Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation
    Hara, Takuma
    Akutsu, Hiroyoshi
    Takano, Shingo
    Kino, Hiroyoshi
    Ishikawa, Eiichi
    Tanaka, Shuho
    Miyamoto, Hidetaka
    Sakamoto, Noriaki
    Hattori, Keiichiro
    Sakata-Yanagimoto, Mamiko
    Chiba, Shigeru
    Hiyama, Takashi
    Masumoto, Tomohiko
    Matsumura, Akira
    JOURNAL OF NEUROSURGERY, 2019, 131 (01) : 217 - 226
  • [10] Functional Analysis of a Novel CTNNB1 Mutation in Pediatric Medulloblastoma
    Alana-Rodrigo, L.
    Nunes-Xavier, C. E.
    Zaldumbide Duenas, L.
    Mosteiro Gonzalez, L.
    Martin Guerrero, I.
    Garcia-Obregon, S.
    Gonzalez Garcia, H.
    Herraiz, R.
    Pulido, R.
    Garcia-Ariza, M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S289 - S289
12345